Endophenotype‐based in silico network medicine methodology for rational design of drug combination in Alzheimer's disease

Abstract

Background: Alzheimer’s disease (AD) is a multifactorial disorder, posing significant challenges to the conventional “one drug, one disease” paradigm. Multi‐targeted therapy and complementary disease gene exposure through drug combinations have the potential to enhance effectiveness.

The paper